Is abaloparatide contraindicated in people with skeletal malignancies or bone metastases?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Yes, abaloparatide (Eladynos) is contraindicated in patients with skeletal malignancies or bone metastases.

EladynosTheramex · emc · SmPC §4.3 Contraindications · Version 1Document updated 11 April 2025

Sources checked 8 November 2026

loading page…

learn & practise

clinical reference

trust & support

legal

Abaloparatide · Medicine question

iatroX medicinesPublished 8 November 2026

The answer

Yes, abaloparatide (Eladynos) is contraindicated in patients with skeletal malignancies or bone metastases.

EladynosTheramex · emc · SmPC §4.3 Contraindications · Version 1Document updated 11 April 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Read the wider context, including uses, precautions and the sources behind this medicine guide.